期刊文献+

18F-阿法肽的自动化制备及其前列腺癌PET/CT显像

Automatic preparation of 18F-AlfatideⅡand its PET/CT imaging in prostate cancer
原文传递
导出
摘要 目的:探讨基于CFN-100氟多功能模块自动化制备18F-阿法肽(AlfatideⅡ)的方法并进行前列腺癌显像。方法:通过氟离子分装器分出200~500μl氟离子至反应管中,与标记前体1,4,7-三氮杂环壬烷-1,4,7-三乙酸-E[(聚乙二醇)4-环(精氨酸-甘氨酸-天冬氨酸-D-苯丙氨酸-酪氨酸)]2{NOTA-E[PEG 4-c(RGDfk)]2}(冻干药盒)反应,在水相中与18F经铝介导螯合标记,再经C18柱分离纯化,自动化制备得到18F-阿法肽,测定其放化产率。对18F-阿法肽注射液进行质量分析,并对2例前列腺癌患者(72岁和66岁)行18F-阿法肽PET/CT显像。结果:采用结合双管路氟离子分装器的CFN-100氟多功能模块成功自动化制备18F-阿法肽,合成时间约30 min,放化产率为(28±3)%(非衰变校正,n=6),放化纯>98%,比活度为2.8×10^7 MBq/mmol,核素纯度大于99%。2例患者PET/CT显像示18F-阿法肽高度浓聚于前列腺癌病灶,最大标准摄取值(SUV max)分别为35.6和5.0。结论:利用改进的CFN-100氟多功能模块成功自动化制备18F-阿法肽,产物合成方法稳定,合成时间短,放化产率高,可高度浓聚于前列腺癌病灶。 Objective To prepare 18F-AlfatideⅡautomatically based on the improved CFN-100 fluorine multifunctional module and assess its PET/CT imaging in prostate cancer patients.Methods A certain volume(200-500μl)of fluoride ion was separated into the reaction tube by a fluoride ion separator and reacted with the labeled precursor l,4,7-triazacylononane-1,4,7-triacetic acid-E[(polyethylene glycol)4-cyclo(Arg-Gly-Asp-D-Phe-Tyr)]2(NOTA-E[PEG4-c(RGDfk)]2)(lyophilized kit).In the aqueous phase,18F was chelated with aluminum.After being separated and purified by C18 column,18F-AlfatideⅡwas prepared automatically.The radiochemical yield and its quality were analyzed.Quality control was carried out and 18F-AlfatideⅡPET/CT imaging was performed in 2 patients(72 and 66 years old)with prostate cancer.Results 18F-AlfatideⅡwas prepared automatically by the improved CFN-100 fluorine multifunctional module combined with a double channel-fluorine ion separation device.18F-AlfatideⅡwas synthetized in about 30 min,with radiochemical yield of(28±3)%(non-decay corrected,n=6).The radiochemical purity of the product was more than 98%,the specific activity was 2.8×10^7 MBq/mmol and the nuclear purity was>99%.PET/CT imaging of 2 patients showed that 18F-AlfatideⅡwere highly concentrated in prostate cancer lesions with the maximum standardized uptake value(SUVmax)of 35.6 and 5.0,respectively.Conclusion 18F-AlfatideⅡcan be prepared successfully by improved CFN-100 fluorine multifunctional module with stable synthesis method,short synthesis time and high radiochemical yield,which can be highly concentrated in prostate cancer.
作者 陈礼平 潘栋辉 张雨 杜晓庆 贺慧慧 杨敏 郁春景 Chen Liping;Pan Donghui;Zhang Yu;Du Xiaoqing;He Huihui;Yang Min;Yu Chunjing(Department of Nuclear Medicine,Affiliated Hospital of Jiangnan University,the Fourth People′s Hospital of Wuxi,Wuxi 214062,China;NHC Key Laboratory of Nuclear Medicine,Jiangsu Key Laboratory of Molecular Nuclear Medicine,Jiangsu Institute of Nuclear Medicine,Wuxi 214063,China)
出处 《中华核医学与分子影像杂志》 CAS 北大核心 2020年第12期731-735,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 无锡市科技发展资金(WX0303B010518180012PB) 江苏省医学创新团队(CXTDA2017024)。
关键词 肽类 精氨酸-甘氨酸-天冬氨酸 氟放射性同位素 化学技术 合成 前列腺肿瘤 正电子发射断层显像术 体层摄影术 X线计算机 Peptides,cyclic Arg-Gly-Asp Fluorine radioisotopes Chemistry techniques,synthetic Prostatic neoplasms Positron-emission tomography Tomography,X-ray computed
  • 相关文献

参考文献2

二级参考文献20

  • 1纪小龙,吉米.甲状腺病理诊断[M].北京:人民军医出版社.2011:131-135.
  • 2Campos LA,Picado SM,Guimar(a)es AV,et al.Thyroid papillary carcinoma associated to Hashimoto's thyroiditis[J].Braz J Otorhinolaryngol,2012,78:77-80.
  • 3Yang M,Gao H,Sun X,et al.Multiplexed PET probes for imaging breast cancer early response to VEGF121/rGel treatment[J].Mol Pharm,2011,8:621-628.
  • 4Yang M,Gao H,Yan Y,et al.PET imaging of early response to the tyrosine kinase inhibitor ZD4190[J].Eur J Nucl Med Mol Imaging,2011,38:1237-1247.
  • 5Wan W,Guo N,Pan D,et al.First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination[J].J Nucl Med,2013,54:691-698.
  • 6Coenen HH,Elsinga PH,Iwata R,et al.Fluorine-18 radiopharmaceuticals beyond[18F]FDG for use in oncology and neurosciences[J].Nucl Med Biol,2010,37:727-740.
  • 7Zhao D,Jin X,Li F,et al.Integrin αvβ3 imaging of radioactive iodine-refractory thyroid cancer using 99Tcm-3PRGD2[J].J Nucl Med,2012,53:1872-1877.
  • 8Beer AJ,Grosu AL,Carlsen J,et al.[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck[J].Clin Cancer Res,2007,13(22 Pt 1):6610-6616.
  • 9Kenny LM,Coombes RC,Oulie I,et al.Phase Ⅰ trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AHl11585 in breast cancer patients[J].J Nucl Med,2008,49:879-886.
  • 10Liu S,Liu Z,Chen K,et al.18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression[J].Mol Imaging Biol,2010,12:530-538.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部